Alembic Pharmaceuticals announces USFDA Final Approval for Doxycycline Capsules, 40 mg
28th June 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA)…